UrgoTul Ag

INDICATIONS

All wounds at risk or with signs of local infection in the granulation and epithelialisation stages

• Chronic wounds
  • Leg ulcers
  • Pressure injuries
• Acute wounds
  • Partial thickness burns
  • Dermabrasions
  • Traumatic wounds
  • Surgical wounds
• Due to the non-adhesive nature of the dressing, it is recommended in the treatment of wounds in which the skin around the lesion is weakened.

CONTRAINDICATIONS

• Known sensitisation to Silver and other ingredients of the dressing.
• Do not use on patients undergoing Magnetic Resonance Imaging (MRI) examination.

PRECAUTIONS

• Treatment with UrgoTul Ag should be carried out under medical supervision.
• Use of this dressing does not negate the need for appropriate systemic anti-bacterial treatment of infected wounds in line with local policy.
• Urgotul Ag/Silver can adhere to surgical gloves (latex). Consequently, it is recommended that the gloves be moistened with normal saline in order to make it easier to hold the dressing.
• Concomitant use with other local treatments is not recommended.
• Do not use in pregnant or breast-feeding women, newborn and premature babies in the absence of any specific clinical data.
• Clinicians / Healthcare Professionals should be aware that there are very limited data on:
  • prolonged and repeated use of silver containing dressings, particularly in children and neonates, and,
  • use of silver containing dressings during radiation treatment.
• The use of UrgoTul Ag in these cases is left to the discretion of the healthcare professional.
• Avoid contact with electrodes or conductive gels during electronic measurements, e.g. EEG and ECG.
• Do not use in a hyperbaric chamber.
• Single-use, individual and sterile dressing: The reuse of a single use product may entail risks of infection.
• (*) Check that the sterile protector is intact before use. Do not use if package is damaged.
• Do not re-sterilise.

CUTTING GUIDE

DIRECTIONS FOR USE

Dressing Changes

• The UrgoTul Ag dressing can be changed every 1 to 3 days depending on the wound treated and the course of healing
• After a maximum of 14 days, a medical assessment is required to determine whether the therapeutic goal has been achieved in order to switch the treatment to a silver-free dressing, and if not, to re-evaluate the suitability of continuing treatment with a silver dressing.
• The maximal duration of the treatment with UrgoTul Ag is one month.

PRODUCT OPTIONS

CLINICAL EVIDENCE

1. DalacS., SigalL., AddalaA., et al Clinical evaluation of a dressing with poly absorbent fibres and a silver matrix for managing chronic wounds at risk of infection: a non-comparative trial. J Wound Care, Vol 25, No 9, September 2016
2. LazarethI., MeaumeS., Sigal-Grinberg M-L, et al. The Role of a Silver Releasing Lipido-colloid Contact Layer in Venous Leg Ulcers Presenting Inflammatory Signs Suggesting Heavy Bacterial Colonization: Results of a Randomized Controlled Study. WOUNDS 2008;20(6):158–166
3. UrgoTulAg data on file